Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.68 USD | +1.78% | -13.90% | -39.57% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.57% | 3.68B | |
+52.99% | 55.7B | |
+40.26% | 39.91B | |
-6.79% | 39.57B | |
-6.65% | 28.16B | |
+14.55% | 26.3B | |
-20.36% | 18.94B | |
+30.61% | 12.17B | |
+26.52% | 12.12B | |
+0.16% | 12.12B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing